Mazdutide

Developed as an oxyntomodulin-based dual agonist, Mazdutide has attracted significant scientific interest due to its ability to activate both GLP-1 and glucagon receptor systems. Its dual-receptor pharmacology has made it an important subject in metabolic and endocrine research. Preclinical and clinical investigations have examined Mazdutide in relation to GLP-1 receptor signalling, glucagon receptor activation, and intracellular pathways associated with metabolic adaptation. 

Ongoing research focuses on understanding its dual-agonist mechanisms, signal transduction pathways, and applications across endocrinology, physiology, and peptide research models.

Research Applications

• GLP-1 receptor signalling studies
• Glucagon receptor pathway investigations
• Dual-agonist receptor mechanism research
• Metabolic physiology studies
• Endocrine signalling pathway analysis
• Energy balance and metabolic adaptation research
• Molecular physiology and peptide biology investigations
• Receptor-mediated cellular communication studies